Evidence map›Paper›PMID 33652895›Full record

ArticleMicroorganisms2021

Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment.

Mia J Biondi, Lauren Garnett, Alexander Bello, Duane Funk, Philippe Guillaume Poliquin, Shane Jones, Kevin Tierney, Kaylie Tran, Robert A Kozak, Anders Leung and 62 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

72 authors at 11 institutions in 2 countries.

Mia J BiondiToronto Centre for Liver Disease, University Health Network, Toronto, ON M5G 2C4, Canada.ORCID 0000-0002-1409-9908
Lauren GarnettNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Alexander BelloNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Duane FunkNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Philippe Guillaume PoliquinNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Shane JonesNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Kevin TierneyNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Kaylie TranNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Robert A KozakDepartment of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON M5S1A8, Canada.
Anders LeungNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Allen GrollaNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Cory NakamuraNational Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB M3E 3M4, Canada.
Geoff SouleNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Charlene RanadheeraNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Mable HaganNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Amrinder DhaliwalMedtronic Canada, Winnipeg, MB M3A 1R9, Canada.
Darwyn KobasaNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.ORCID 0000-0002-6371-7493
Darryl FalzaranoVaccine and Infectious Disease Organization-International Vaccine Centre, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.
Hugues Fausther BovendoCentre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Université Laval, Quebec City, QC G1V 4G2, Canada.
Heinz FeldmannLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.ORCID 0000-0001-9448-8227
Murray KesselmanDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Gregory HansenFaculty of Critical Care, Royal University Hospital, Saskatoon, SK S7N 0W8, Canada.
Jason GrenNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Todd MortimerDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Trina RacineVaccine and Infectious Disease Organization-International Vaccine Centre, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.ORCID 0000-0001-6370-8661
Yvon DeschambaultNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Jocelyn EdmondsDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Sam AminianDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Ray SauretteDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Mark AllanDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Lauren RondeauDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
John HuynhDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Sharron HadderDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Christy PressDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Christine DeGraffNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Stephanie KucasNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Julie KubayNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Kimberly AzanarskyNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Bradley W M CookCytophage Technologies, Inc., Winnipeg, MB R3Y 1G4, Canada.
B J HancockDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Anand KumarDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Reeni SoniDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Daryl SchantzDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Jarrid McKitrickDepartment of Medical Microbiology and Infectious Diseases, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
Bryce WarnerNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.ORCID 0000-0003-2635-5072
Bryan D GriffinNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Xiangguo QiuNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Gary P KobingerCentre de Recherche en Infectiologie, Centre Hospitalier Universitaire de Québec, Université Laval, Quebec City, QC G1V 4G2, Canada.
Dave SafronetzNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Heidi WoodNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Derek R SteinCadham Provincial Laboratory, Winnipeg, MB R3E 37J, Canada.
Todd CuttsNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Brad PickeringDepartment of Medical Microbiology and Infectious Diseases, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.ORCID 0000-0002-8613-5402
James KennyDepartment of Paediatrics & Child Health, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1S1, Canada.
Steven TheriaultCytophage Technologies, Inc., Winnipeg, MB R3Y 1G4, Canada.
Liam MenecNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Robert VendramelliNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.ORCID 0000-0002-9131-2602
Sean HigginsNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Logan BanadygaNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.ORCID 0000-0001-8390-2648
Guodong LiuNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Md Niaz RahimNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.ORCID 0000-0001-7667-8430
Samantha KasloffNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Angela SloanNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.ORCID 0000-0001-7467-0144
Shihua HeNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Nikesh TailorNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Alixandra AlbietzNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Gary WongDepartement of Microbiology-Infectiology and Immunology, Université Laval, Québec City, QC G1V 0A6, Canada.
Michael GrayNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Friederike FeldmannLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
Andrea MarziLaboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.ORCID 0000-0003-0186-9587
George RisiInfectious Disease Specialist, P.C., Missoula, MT 59802, USA.
James E StrongNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB R3E 3M4, Canada.
Public Health Agency of Canada · CAUniversity of Manitoba · CANational Institutes of Health · USCanadian Food Inspection Agency · CACentre hospitalier universitaire de Québec · CAUniversity of Saskatchewan · CAMedtronic (Canada) · CARoyal University Hospital · CAUniversité Laval · CAUniversity Health Network · CAUniversity of Toronto · CA

Funding

Viral Hemorrhagic Fevers: Disease Modeling and TransmissionZIAAI001089 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI FELDMANN, HEINRICH · 2009 to 2025
$50.7M
Immunobiology, molecular virology and countermeasures of highly pathogenic virusesZIAAI001254 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MARZI, ANDREA · 2020 to 2025
$16.6M
CIHR FRN143481
6 · The paper itself

Abstract

backgroundThe 2014-2016 Ebola outbreak in West Africa recapitulated that nosocomial spread of Ebola virus could occur and that health care workers were at particular risk including notable cases in Europe and North America. These instances highlighted the need for centers to better prepare for potential Ebola virus cases; including understanding how the virus spreads and which interventions pose the greatest risk.

methodsWe created a fully equipped intensive care unit (ICU), within a Biosafety Level 4 (BSL4) laboratory, and infected multiple sedated non-human primates (NHPs) with Ebola virus. While providing bedside care, we sampled blood, urine, and gastric residuals; as well as buccal, ocular, nasal, rectal, and skin swabs, to assess the risks associated with routine care. We also assessed the physical environment at end-point.

resultsAlthough viral RNA was detectable in blood as early as three days post-infection, it was not detectable in the urine, gastric fluid, or swabs until late-stage disease. While droplet spread and fomite contamination were present on a few of the surfaces that were routinely touched while providing care in the ICU for the infected animal, these may have been abrogated through good routine hygiene practices.

conclusionsOverall this study has helped further our understanding of which procedures may pose the highest risk to healthcare providers and provides temporal evidence of this over the clinical course of disease.

Indexed as

critical careEbolaenvironmental contaminationnosocomial infectionviral shedding

Identifiers

PMID33652895
PMCPMC7996731
OpenAlexW3134982649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.